Drägerwerk stock at EUR 111.50, 11.1 percent below yearly high
Published on 10/08/2026 at 18:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- Drägerwerk stock was EUR 111.50 at Lang & Schwarz on October 8, 2026, down 1.33 percent versus EUR 113.00.
- The price stood 11.08 percent below the EUR 125.40 52-week high on October 8, 2026.
- Market capitalization was EUR 2.1 billion, with a P/E ratio of 12.19 as of October 8, 2026.
- Drägerwerk's next scheduled quarterly results are due on October 29, 2026.
- The capital markets day is scheduled for November 18, 2026.
Drägerwerk stock was trading at EUR 111.50 at Lang & Schwarz on October 8, 2026 at 6:19 p.m. CEST, down 1.33 percent versus the prior close of EUR 113.00. The after-hours quote places the share 11.08 percent below its EUR 125.40 52-week high.
Price sits below yearly high
The intraday picture is defined by the gap to the yearly peak rather than a fresh corporate event. Lang & Schwarz showed a bid of EUR 111.20 and an ask of EUR 111.80 at the same October 8, 2026 snapshot, giving investors a spread of EUR 0.60.
The structured market quote showed 15,145 shares traded on October 8, 2026, compared with an average volume of 20,115 shares. That places the session volume at 24.71 percent below the stated average, a concrete sign of lighter activity alongside the lower price.
Valuation and trading activity
Drägerwerk's market capitalization stood at EUR 2.1 billion on October 8, 2026. The P/E ratio was 12.19, while the trailing dividend yield was 2.00 percent. These figures describe the valuation snapshot and do not constitute an investment recommendation.
The company operates in medical and safety technology, according to Drägerwerk. That combination makes the peer comparison useful because the medical equipment group and the safety business expose the stock to different demand patterns.
Comparison with peers
Drägerwerk: minus 1.33 percent, P/E 12.19, market capitalization EUR 2.1 billion
Siemens Healthineers (Xetra, EUR): minus 0.78 percent, P/E 19.32, market capitalization EUR 42.8 billion
Getinge (Nasdaq Stockholm, SEK): minus 0.16 percent, P/E 25.39, market capitalization SEK 68.0 billion
Next date on the calendar
The next scheduled quarterly results are due on October 29, 2026, according to Finanztrends. Drägerwerk's capital markets day is scheduled for November 18, 2026, as stated in the company's first-half earnings call published by Yahoo Finance on July 30, 2026.
Market report reference
Germany's benchmark reference remains the DAX, while Drägerwerk trades at a market value of EUR 2.1 billion as of October 8, 2026.
After-hours quote sets the level
The Drägerwerk quote was trading at EUR 111.50 at Lang & Schwarz on October 8, 2026 at 6:19 p.m. CEST, minus 1.33 percent versus the Lang & Schwarz prior close of EUR 113.00. The further course of trading is shown by the continuously updated real-time quote of Drägerwerk stock.
Drägerwerk stock facts
- Company: Drägerwerk AG & Co. KGaA
- ISIN: DE0005550636
- Ticker: DRW3
- Price Lang & Schwarz (as of October 8, 2026, 6:19 p.m. CEST): EUR 111.50
- Change versus prior close: minus 1.33 percent
- Prior close Lang & Schwarz (October 7, 2026): EUR 113.00
- Market capitalization: EUR 2.1 billion (as of October 8, 2026)
- 52-week range: EUR 64.90-125.40 (as of October 8, 2026)
- Sector / Industry: Health Care / Medical Equipment
Market context: Market report DAX.
